![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 45, 32439-32444, November 5, 1999
From the Unité de Génétique Moléculaire des
levures (URA 1300 CNRS and UPR 927 Université P. M. Curie),
Institut Pasteur, Département des Biotechnologies, 25 Rue du
Docteur Roux, 75724 Paris Cedex 15, France
Nup145p is a component of the nuclear pore
complex of Saccharomyces cerevisiae and is essential for
mRNA export. Nup145p and its apparent vertebrate homologue are the
only known nucleoporins to be composed of two functionally independent
peptide moieties resulting from the post-translational cleavage of a
large precursor molecule. In this study, the proteolytic cleavage site
of Nup145p has been mapped upstream of an evolutionary conserved serine
residue. Cleavage occurs at the same site when a precursor is
artificially expressed in Escherichia coli. A
hydroxyl-containing residue is critical for the reaction, although a
thiol-containing residue offers an acceptable replacement. In
vitro kinetics experiments using a purified precursor molecule
demonstrate that the cleavage is self-catalyzed and that the catalytic
domain lies within the N-terminal moiety. Taken altogether, our data
are consistent with a proteolytic mechanism involving an N>O acyl
rearrangement and a subsequent ester intermediate uncovered in other
self-processing proteins.
Nuclear pore complexes
(NPCs)1 are large structures
through which nucleocytoplasmic exchange of soluble macromolecules
occurs in eukaryotic cells. The NPCs of yeast and higher eukaryotes
share the same basic architecture, including a characteristic 8-fold symmetry, and are believed to be functionally similar (1-3). Constitutive and regulated import or export through NPCs is generally energy-dependent and requires substrate-specific
transporters that are targetted to the NPC via repeat-containing
nucleoporins (or nuclear pore proteins) (4-6). In yeast, about 30 nucleoporins have already been identified (7). Yet their precise role
in transport reactions and/or in NPC biogenesis is far from being understood.
One of the components of the NPC of Saccharomyces
cerevisiae, Nup145p, is expressed as a 145-kDa precursor that is
rapidly processed to yield two moieties, a N-terminal domain of 65 kDa (N-Nup145p) and a C-terminal domain of 80 kDa (C-Nup145p) (8, 9).
Repression of NUP145 (YGL092w) leads to the rapid
accumulation of mRNA molecules in the nucleus, concomitant with a
nucleolar disorganization and a clustering of NPCs (10-12).
Previous experiments in which the N- and C-Nup145p domains were
expressed separately or as a part of a noncleavable precursor have
shown that the two moieties perform distinct functions in the cell (9).
C-Nup145p is a component of a NPC subcomplex that includes Nup120p,
Nup85p, Nup84p, Seh1p, and Sec13p (9, 13). Mutations in most of these
nucleoporins, including C-Nup145p, severely affect mRNA export and
nuclear architecture (8, 9, 12, 13). The mature N-Nup145p domain does
not belong to this complex. Nevertheless, deletion of the corresponding
part of the NUP145 gene is lethal in a genetic context where
other nucleoporins, such as Nup188p and Nic96p, are mutated (9).
Whereas the function of C-Nup145p is not disturbed in mutants of
Nup145p where processing is abolished, the function of N-Nup145p is
affected as judged from its interaction with Nup188p. In addition,
mislocalization of N-Nup145p in the nucleoplasm occurs when it is
expressed separately from C-Nup145p (9). Thus, the existence of a
precursor molecule, followed by its processing, are a requisite for the
function of N-Nup145p for reasons that remain to be elucidated.
Interestingly, the processing of Nup145p is conserved in evolution. It
was recently reported that the putative rat homologue of Nup145p is
expressed as a Nup98-Nup96 precursor that is also cleaved in
vivo to generate two nucleoporins, the previously characterized nucleoporin Nup98 (14-16), which shares similarity with N-Nup145p and
a novel nucleoporin, Nup96 (17). Nup98, expressed independently from an
alternatively spliced mRNA is also proteolytically processed (17).
As in yeast, the correct maturation of the Nup98-Nup96 and Nup98
precursors is essential for the proper localization of the subsequent
cleavage products, suggesting that it may be important for NPC assembly
(17).
In this paper, we demonstrate the self-catalyzed processing of Nup145p
and localize the processing activity in the N-terminal moiety. The data
presented suggest a mechanism involving an ester intermediate as has
been described for other self-processing proteins.
DNA Constructs--
The Escherichia coli expression
vector pE151 was constructed by inserting a
NdeI/BamHI-digested polymerase chain reaction product, obtained using oligonucleotides A and B (Table
I) on a GST-NUP145
fusion gene (10), into pET16b (Novagen). This vector expresses the
His396NC891His construct.
The yeast expression vector pE165 contains the same construct placed
under the doxycycline repressible promoter of the plasmid pCM190 (18).
This construct was obtained by co-transformation (19) in yeast strain
FYBL2-5D (20) of a polymerase chain reaction product (using
oligonucleotides C and D on pE151) with the pCM190 linearized DNA (21).
Expression was monitored by Western blotting, and the recombinant
plasmid was subsequently transformed (22) into the protease-deficient
yeast strain BJ2168 (23).
The vectors pE172-175 expressing the
His398NC613HA proteins were constructed as was
pE151 except that the polymerase chain reaction product was amplified
using oligonucleotides E (which introduces the RRASV site) and any of
oligonucleotides F, G, H, and I (which introduce the HA tag preceded by
the wild type and S606C, S606T, and S606A mutations, respectively). The
inserts of these plasmids were completely sequenced (by the
MWG-Biotech). For cloning manipulations E. coli strains TG1
(Transgene) or XL2-blue (Stratagene) were used.
Total Protein Extracts and Western Blotting--
Purified tagged
proteins or those in total extracts from yeast (9) or E. coli (24) were detected by Western blot using the anti-N-Nup145p
polyclonal antibody (10), a monoclonal (HIS-1) anti-polyhistidine-peroxidase conjugate (Sigma), diluted at 1:10,000 and anti-HA-peroxydase conjugate at a dilution 1:500. The peroxidase conjugates were revealed with ECL (Amersham Pharmacia Biotech).
His396NC891His Purifications--
Yeast
cells expressing the His396NC891His
construct were grown in 1 liter of minimal medium (25) lacking uracil
to an A600 of 7.8, washed, frozen at
E. coli cells BJ21(DE3)pLysS (Novagen) expressing the
His396NC891His construct were induced
overnight in 800 ml of LB medium containing 100 µg/ml ampicillin, 34 µg/ml chloramphenicol, and 1 mM
isopropyl-1-thio- Microsequencing and Mass Spectrometry
Determination--
N-terminal sequences of the His396N and
C891His fractions purified in yeast and E. coli
(see Fig. 2) were determined by Edman degradation. In the Ec1 fraction
(see Fig. 2), two minor bands migrating just above the major band
corresponding to C891His (with an N terminus Ser-Ile-Trp)
were also sequenced and revealed N termini Met-Lys-Asp and Met-Arg-Glu,
corresponding to internal sequences of Nup145p at positions 564 and
583, respectively. We suggest that these forms correspond to products
of internal initiations of translation that could not be processed. For
the mass-spectrometry determination, 150 µg of purified
His396N from E. coli (fraction Ec2; see Fig. 2)
was dialyzed against 50 mM ammonium bicarbonate and
lyophilized. An aliquot of the pellet was dissolved in 100 µl of
water/methanol/formic acid (50:50:10) and introduced to a API 365 triple quadrupole mass spectrometer (PE-Sciex, Thornill, Canada).
Precursor Purification--
BL21(DE3)pLysS cells expressing the
His398NC613HA(S606C) precursor were grown as
above, induced by addition of 1 mM
isopropyl-1-thio- Radioactive Labeling of Purified Proteins and in Vitro Cleavage
Assays--
The His398NC613HA construct
containing the RRASV site was used for in vitro labeling
(26, 27). Briefly, 10 µg of freshly purified mixture
His398NC613HA(S606C):His398N were
incubated for 5 min with 6.3 units of the catalytic subunit of the
protein kinase (Sigma) in 20 mM Tris, 100 mM
NaCl, 12 mM MgCl2, 2.8 mM DTT, and
50 µCi of [ Analysis of the Cleavage Products of Nup145p--
Previous results
suggested that cleavage of Nup145p (Fig.
1) occurs around residues 603-606 (9),
but the cleavage site was not located precisely. Therefore, as a first
step toward characterization of the processing mechanism, we decided to
characterize the cleavage products of Nup145p. To do so, a truncated
version of Nup145p (10) containing the expected cleavage region and
fused at its N and C termini with several His residues
(His396NC891His; Fig. 1) was overexpressed in
yeast and purified by affinity chromatography using a Nickel column. A
Coomassie Blue staining of the purified products (Fig.
2, lane Sc) shows a major band corresponding in size to the His396N (around 30 kDa) and a
minor band corresponding in size to the C891His (around 40 kDa), demonstrating that this truncated construct retains the capacity
to be cleaved in vivo. The difficult solubilization of
C891His under the native conditions used for this
experiment might account for the nonstoichiometry of the two cleavage
products. Despite its low abundance, the C891His moiety was
gel purified and subjected to Edman degradation. The sequence
Ser-Ile-Trp was found at the N terminus of C891His. This
sequence corresponds to a unique internal sequence of Nup145p at
positions 606-609 (Fig. 1) and thus demonstrates cleavage of the
peptide bond immediately upstream of the serine 606.
Nup145p Cleavage Occurs in Heterologous
System--
Autoproteolysis at internal sites preceding serine,
cysteine, or threonine positions is now established for several
proteins (28). It was therefore tempting to hypothesize that cleavage of Nup145p could proceed by the same mechanism. To test this
possibility, we decided to examine the maturation of Nup145p in a
heterologous expression system. The same truncated protein
His396NC891His was expressed in E. coli and purified under denaturing conditions on a Nickel column
followed by an anion exchange chromatography. Analyzed fractions
contained mainly the His396N or the C891His
form (Fig. 2, lanes Ec2 and Ec1, respectively),
confirming that the cleavage of this precursor also takes place in
E. coli. Note that the His396N produced in
E. coli has a slightly slower electrophoretic mobility in
SDS-PAGE than the His396N produced in yeast. This might be
due to post-translational modifications in S. cerevisiae
(see "Discussion").
N-terminal microsequencing of the C891His gel purified band
(Fig. 2, lane Ec1) revealed an N terminus beginning with the
sequence Ser-Ile-Trp, showing that the N terminus of
C891His generated by in vivo cleavage is the
same in yeast and E. coli. Thus, Nup145p cleavage either
requires a trans-acting factor that is present in E. coli or is catalyzed by the Nup145p protein itself.
The results presented above show that cleavage occurs at the peptidyl
bond preceding the serine 606 generating a free amino group. To
characterize the C-terminal generated by the proteolytic reaction, we
analyzed the purified His396N produced in E. coli (Fig. 2, lane Ec2) by mass spectrometry. One peak
at 26,428 ± 83 Da was obtained that corresponds to the theoretical mass expected for the His396N lacking the first
methionine (26,427.41 Da). N-terminal microsequencing of the gel
purified band (Fig. 2, lane Ec2) indeed confirms that His396N starts with the glycine immediately following the methionine.
From these measurements, we conclude that proteolysis occurs between
phenylalanine 605 and serine 606 and that the last residue of
His396N generated by cleavage is not additionally modified.
Cleavage in E. coli is therefore the result of hydrolysis of
the 605-606 peptide bond, generating two peptides with free C and N termini.
Role of the Hydroxyl Side Chain of the Serine
606--
Self-proteolysis reactions preceding serines, cysteines, or
threonines involve a nucleophilic attack by the hydroxyl or thiol group
of the respective amino acids on the preceding peptide bond, resulting
in the replacement of the peptide bond by an ester or a thioester bond
(28). These bonds are more reactive than the peptide bonds and can then
be attacked by a second nucleophile and broken. This model implies that
any of the three residues serine, cysteine, or threonine is essential
for the reaction and can be replaced by one another with only limited
effects on catalytic activity (29, 30).
Because Nup145p cleavage takes place before a serine, we tested the
importance of the hydroxyl residue in the reaction. Therefore, serine
606 was replaced by a cysteine, a threonine, or an alanine by directed
mutagenesis. For experimental purposes, we used an even shorter
truncated version of Nup145p (His398NC613HA;
Fig. 1), where the C-Nup145p is almost entirely substituted by the HA
tag. Each construct was then transformed into E. coli, and
expression of the encoded protein was induced. The processing capacity
of the different precursors was analyzed at different times after
induction (Fig. 3).
For the wild type form His398NC613HA(WT), a
major band that corresponds in size to the mature N-terminal moiety is
revealed by Western blot using the antibody directed against the His
tag (Fig. 3,
On the contrary, expression of the S606A mutation leads to the
formation of a single major band throughout the kinetics experiment corresponding in size to the precursor and reacting with both anti-His
(Fig. 3,
Expression of the S606C mutant produced two anti-His reacting forms.
They correspond respectively to the precursor form, which also reacts
with the anti-HA antibody and with the mature N-terminal form (Fig. 3),
showing that proteolytic cleavage can take place in this mutant. The
precursor form is the major product at early stages after induction
(Fig. 3, In Vitro Cleavage of a Purified Precursor--
To demonstrate
definitively that the cleavage of the Nup145p precursor is a
self-catalyzed process, we undertook the purification of a precursor
form and tested its ability to undergo self-cleavage in
vitro. Precursor purification from the wild type construct would
be very difficult because of the high efficiency of the in
vivo processing (see above). We therefore made use of the mutants S606C and S606T to define conditions under which the precursor form
accumulates. The best yield of uncleaved precursor was obtained using
the S606C mutant induced for a short time (45 min) at 30 °C (data
not shown). Protein products were then extracted and purified on a
nickel column under native conditions. The purification was assessed by
SDS-PAGE followed by Coomassie Blue staining (Fig. 4A). Two major bands
corresponding respectively to the
His398NC613HA(S606C) precursor and to the
His398N product were obtained, indicating that partial
cleavage of the precursor does occur during extraction but that the
proportion of precursor molecules is sufficiently high to allow
subsequent analysis in in vitro reactions.
To quantify the cleavage reactions, we chose to follow radiolabeled
products. For this purpose, we introduced the artificial pentapeptide
phosphorylation site RRASV (26, 27) following the His tag in the
His398NC613HA construct. Using
[
The next step was to determine adequate conditions for the in
vitro cleavage. To do so, we hypothesized that the requirement for
a hydroxyl (or thiol) group at the cleavage site of Nup145p precursor
reflects the involvement of an ester (or a thioester) intermediate in
the mechanism. Because thioesters are particularly susceptible to
nucleophiles (31), we decided to test for the reactivity of
His398NC613HA(S606C) in the presence of DTT
known to accelerate this type of reaction (30, 32, 33). The in
vitro cleavage was then performed with or without 50 mM DTT at 30 °C, and aliquots of the reaction were
analyzed at different times (Fig. 4B). In the presence of
DTT, the band corresponding to the precursor decreases concomitantly
with the increase of the band corresponding to the mature product. This
precursor-product kinetic relationship demonstrates that
His398NC613HA(S606C) has the capacity to
self-process in vitro into His398N in the
presence of DTT. In the absence of DTT, the ratio
His398NC613HA(S606C):His398N is
maintained during the 2 h of the reaction (Fig. 4B).
Because DTT-induced cleavage could involve the thiol as a nucleophile or as a reductant, we made use of a nonthiol disulfide reductant, the
tris(2-carboxyethyl)phosphine (34). We found that the half-life of the
precursor in the presence of 50 mM
tris(2-carboxyethyl)phosphine was increased 15 times compared with the
reaction in the presence of 50 mM DTT in a 2 h
reaction (see below and data not shown). This suggests that the
accelerating effect of DTT on the in vitro cleavage reaction
is due to its ability to carry out nucleophilic attack. Longer times of
incubation were attempted, but results were obscured by unspecific
secondary reactions, which might be due to partial denaturation of the
precursor. Consistent with this hypothesis is the observation that
reaction is less efficient at higher concentrations of protein,
resulting in its precipitation (data not shown).
Quantification of the reaction was done from three independent
experiments (Fig. 4C). At time 0 of the experiments, the
ratio His398NC613HA(S606C):His398N
was ~60:40. In the presence of DTT, this ratio decreased to about
30:70 in 2 h, whereas in the absence of DTT, it remained unchanged. The points obtained for the incubation in the presence of
DTT suggest a (pseudo) first order reaction, and the precursor half-life time is comprised between 8.6 and 11.5 min. Under the conditions used, approximately half of the purified precursor was able
to cleave into the mature form. The incomplete character of the
reaction might be due to partial denaturation of the molecules as
mentioned above. However, we cannot exclude the possibility that the
independent secondary reactions may become non-negligible at late times
of incubation, either because of the purification process or because of
other uncharacterized proprieties of the precursor.
Post-translational cleavage of the yeast nucleoporin Nup145p
generates two functionally distinct proteins. The different lines of
evidence presented here support the notion that this reaction is
self-catalyzed. First, Nup145p cleavage is observed in heterologous expression systems including E. coli and a mammalian
in vitro transcription/translation system (data not shown).
Second, a purified precursor form of Nup145p is cleaved in
vitro following a (pseudo) first order reaction kinetics (at least
for the early times of the reaction) and cleavage occurs in highly
diluted samples, free of detectable contaminants. The participation of
a hypothetical specific trans-acting factor, conserved in
both prokaryotes and eukaryotes, is therefore highly improbable. Third,
all our results are consistent with the mechanism described for
autoproteolysis taking place in peptide bonds preceding hydroxyl- or
thiol-containing residues; in particular, the in vitro
reaction studied here is dependent upon the presence of DTT.
It has been known since the 1960s that peptide bonds involving
hydroxyl-containing residues can shift to ester bonds (N>O acyl
rearrangement) under laboratory conditions (35). There is now formal
evidence that these reactions exist in several protein maturation
pathways, including protein splicing (36), hedgehog protein
maturation (32), pyruvoyl enzymes (37), and N-terminal nucleophile
hydrolases (29, 38) activations. In these cases, the hydroxyl- or
thiol-containing residues, serine, threonine, or cysteine, undergo a
N>O or a N>S acyl-shift resulting in an ester or thioester bond much
more reactive than the peptide bond. The ester or thioester bond is
then resolved by an attack by a second nucleophile that can be for
example water (N-terminal nucleophile hydrolases) (39) or cholesterol
(hedgehog) (40). Our results do not provide direct evidence
for the exact reaction mechanism involved but are consistent with
previous mechanisms since they include (i) the cleavage site before a
serine, (ii) requirement for a hydroxyl or thiol group at the cleavage
position, (iii) the sensitivity of in vitro cleavage of the
S606C mutant to DTT, and (iv) the incapacity of
tris(2-carboxyethyl)phosphine to promote such a cleavage. In addition,
cleavage of Nup145p in E. coli results from the hydrolysis
of peptide bond 605-606, indicating that water might account for the
second nucleophilic attack. We cannot exclude, however, that the
proteolysis in yeast may involve other modifications, as suggested by
the difference in electrophoretic mobility observed for the
His396N produced in yeast and in bacteria. This situation
may be reminiscent of hedgehog processing, where the
covalent addition of cholesterol during the self-catalyzed processing
results in an increased mobility on SDS-PAGE of the mature protein (40,
41).
The catalytic domain for the proteolysis of Nup145p must be included
between amino acids 398 and 613 because the minimal protein used in
this study, His398NC613HA, is still able to
undergo self-processing. Taken together with other independent
experiments (8), the catalytic site can be narrowed down to the regions
containing amino acids 398-523 and 593-613. Furthermore, deletion of
the region comprised between residues 470 and 551 abolishes cleavage
(10). This latter region contains a RNP-I-like octapeptide motif (Fig.
1) and was proposed to be responsible for RNA affinity of Nup145p
in vitro (10). Preliminary experiments show that point
mutations in this octapeptide also affect cleavage (data not shown),
suggesting that this region may be part of the catalytic site or
necessary for its correct folding.
Nup145p has a putative homologue in vertebrates, Nup98-Nup96, that is
also cleaved in vivo at the serine of the conserved cleavage
site (17). Sequence similarity between Nup98-Nup96 and Nup145p (9, 17)
is particularly extensive in the region that we have determined as
necessary for the self-processing of Nup145p. It can thus be proposed
that the mechanism of processing of the Nup98-Nup96 precursor is also
self-catalyzed. Self-processing systems offer the advantage that the
specificity is built up into a single molecule (42) and limit the
control of the cell over the reaction unless specific interactions may
affect the reaction in vivo. Interestingly, maturation of
either yeast Nup145p or rat Nup98-Nup96, has a direct role in the
localization of the precursor and the subsequent cleavage products (9,
17). Thus, self-cleavage of these nucleoporin precursors may have been
conserved in eukaryotes for the specific targeting to the NPC.
We thank J. D'Alayer for protein sequencing
and A. Namane and O. Barzu for mass spectrometry determination. We also
thank A.-M. Gilles, P. Roux, F. Colland, and A. Jacquier for useful advice during the progression of this work; G. Chanfreau, C. Fairhead, and U. Nehrbass for critical reading of the manuscript; and
all members of the laboratory for fruitful discussions. M. T. T. thanks all participants of the Cold Spring Harbor course on protein
purification and characterization (1998).
Another report of self-catalysis of rat
Nup98 precursor appeared while this article was in press (Rosenblum, J. S., and Blobel, G. (1999) Proc, Natl. Acad. Sci. U. S. A.
96, 11370-11375).
*
This work was supported in part by DGXII of the European
Commission "EUROFAN" Grant BIO4-CT97-2294.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Professor of Molecular Genetics at Université P. M. Curie
and a member of the Institut Universitaire de France.
The abbreviations used are:
NPC, nuclear
pore complex;
PAGE, polyacrylamide gel electrophoresis;
DTT, dithiothreitol;
HA, hemagglutinin.
Self-catalyzed Cleavage of the Yeast Nucleoporin Nup145p
Precursor*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Oligonucleotides used in this work
70 °C,
and resuspended in 25 ml of buffer A (150 mM NaCl, 0.1%
Triton X-100, 20 mM Tris, pH 8) containing 20 mM imidazole. Cells were broken with a French press at
20,000 p.s.i., and the homogenate was clarified by centrifugation at 27,000 × g for 30 min. Supernatant was injected into a
1-ml HiTrap Chelating column (Amersham Pharmacia Biotech) previously
loaded with NiSO4. The column was washed with 5 volumes of
buffer A containing 20 mM imidazole and eluted with a
linear imidazole gradient from 20 to 300 mM in buffer A. The His386N and C891His cleavage products
eluted at the highest concentration of imidazole.
-D-galactopyranoside. Cells were
washed, pelleted, resuspended in buffer B (150 mM NaCl, 0.1% Triton X-100, 20 mM Hepes, 8 M urea, pH
8) containing 20 mM imidazole, and sonicated. The
homogenate was centrifuged at 40,000 × g for 30 min,
and the supernatant was loaded onto a 1-ml HiTrap Chelating column
(Amersham Pharmacia Biotech) in an Àkta purifier system (Amersham
Pharmacia Biotech). The column was washed with buffer B containing 20 mM imidazole and eluted with a linear gradient of imidazole
from 20 to 500 mM in buffer B. The tagged products eluted
at 200 mM imidazole. Fractions were pooled, diluted 1:8 in
buffer C (20 mM Hepes, 8 M urea, pH 8)
containing 20 mM NaCl, injected into a 1-ml HiTrap Q column
(Amersham Pharmacia Biotech), and eluted with a linear gradient of NaCl
from 20 to 600 mM in buffer C. Two major peaks containing,
respectively, the His396N (100 mM NaCl,
fraction Ec2; see Fig. 2) and the C891His (350 mM NaCl, fraction Ec1; see Fig. 2) were kept for analysis.
-D-galactopyranoside and incubated for
45 min at 30 °C. Cells were washed, and the pellet was frozen at
70 °C and resuspended in 10 ml of buffer A containing 20 mM imidazole supplemented with 1 mg of DNase I and 1 mg of
RNase A. The homogenate was clarified by centrifugation at 40,000 × g for 15 min and injected to a 1-ml HiTrap Chelating column as above. The column was washed with buffer A containing 20 mM imidazole until the A280 of the
eluant reach a minimum and then eluted with a linear gradient of
imidazole from 20 to 500 mM in buffer A. A peak at 300-400
mM imidazole contained 500 µg of the mixture
His398NC613HA(S606C):His398N in a
ratio of approximately 60:40 (see below). To prevent cleavage, it was
essential to work rapidly and maintain the temperature during the
purification at 4 °C or less.
-32P]ATP (at >4000 Ci/mmol, ICN) in a
total reaction volume of 50 µl. The protein was then separated from
the nonincorporated nucleotides by gel filtration on Bio-gel P
(Bio-Rad). For time course experiments, 32P-labeled
proteins were incubated at a concentration of about 100 nM
in 300 mM NaCl, 20 mM Hepes, 0.1% Triton
X-100, pH 8, with or without 50 mM DTT. Reactions were then
analyzed by SDS-PAGE on a 13% gel, exposed to PhosphorImager
cassettes, and analyzed by ImageQuant (Molecular Dynamics). ImageQuant
graphs corresponding to the radioactivity along the gel lane were
further analyzed by Igor (WaveMetrix, Inc.) using a double gaussian
curve fitting procedure (a kind gift from A. Jacquier). The double
gaussian curve was then resolved into two single gaussians and integrated.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (9K):
[in a new window]
Fig. 1.
A schematic representation of the wild type
Nup145p and its truncated versions. In the wild type, positions of
the GLFG repeats, the NRM domain and the RNP-I like motif are depicted
(10). The sequence surrounding the cleavage site (arrow) is
detailed. First and last amino acid residues of the truncated versions
of Nup145p are indicated. The His tag is represented by vertical
stripes, and the HA epitope is indicated by dots. All
amino acid positions in this paper are relative to the wild type
Nup145p (10, 11).

View larger version (76K):
[in a new window]
Fig. 2.
Cleavage products of Nup145p in yeast and
E. coli. His396NC891His
precursor products purified from S. cerevisiae
(Sc) and E. coli (Ec) were analyzed by
SDS-PAGE (8-16% precast gel, Bio-Rad) followed by Coomassie Blue
staining. Ec1 and Ec2 correspond to the two major
peaks recovered after the anion exchange chromatography and contain,
respectively, the His396N (Ec2) and the C891His
(Ec1). The weak band corresponding to mature C891His in
yeast is marked with a dot. STD stands for
protein standards.

View larger version (25K):
[in a new window]
Fig. 3.
A hydroxyl- or thiol-containing residue is
critical for cleavage. Total protein extracts from E. coli expressing the His398NC613HA
constructs harboring either the wild type (WT) or the
mutated (S606C, S606T, and S606A) cleavage site were incubated for
various time intervals after induction, separated by SDS-PAGE (13%
gel) and transferred to nitrocellulose. The tagged proteins were
detected using either anti-His (
-His) or anti-HA (
-HA)
antibodies. Note that the minor anti-His reacting band above the mature
His398N in WT does not correspond in size to the precursor
form.
-His). This band is nearly constant in
intensity for all time points analyzed after induction. The antibody
directed against the HA tag only detects a faint band migrating
about 2 kDa above the mature form as expected for the precursor
molecule (Fig. 3,
-HA). This experiment indicates that
the truncated version of Nup145p retains the capacity to undergo
cleavage in vivo and that the processing is already
efficient even at early stages after induction. Thus, deletion of most
C-Nup145p does not affect the cleavage capacity.
-His) and anti-HA (Fig. 3,
-HA)
antibodies. Thus, the S606A mutation completely abolishes proteolytic
cleavage of the precursor molecule.
-His, 1.5 h and decreases at later
stages (Fig. 3,
-His, 6 h. This shows that the
cleavage reaction is delayed in this mutant compared with the results
obtained for the wild type. The situation is similar for the S606T
mutant, with the difference that the ratio of precursor to product
observed along the time course is slightly lower, suggesting that this mutation is less deleterious to the cleavage reaction in
vivo. Overall, these results suggest that a hydroxyl- or
thiol-containing residue at the cleavage junction is required for the reaction.

View larger version (30K):
[in a new window]
Fig. 4.
In vitro cleavage of Nup145p in
the mutated version His398NC613HA(S606C).
A, E. coli
His398NC613HA(S606C):His398N
purified mixture resolved by SDS-PAGE (13% gel) and stained with
Coomassie Blue. STD stands for protein standards.
B, the purified mixture was radiolabeled and diluted in the
reaction buffer with (+DTT) or without (
DTT) 50 mM DTT. The samples taken at different times were analyzed
by SDS-PAGE (13% gel) and gel scanning. Total amounts of radioactivity
are not significantly different between lanes. C,
quantification of three independent experiments as in
B.
-32P]ATP as substrate, the purified mixture
His398NC613HA(S606C):His398N was
labeled by phosphorylation using a commercial bovine kinase. Analysis
of proteins by SDS-PAGE followed by gel scanning shows that both
His398NC613HA(S606C) and His398N
were successfully labeled (Fig. 4B, 0 min).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
Note Added in Proof
![]()
FOOTNOTES
Recipient of the Fundação para a Ciência e
Tecnologia and PRAXIS XXI Program Grant BD/5226/95). To whom
correspondence should be addressed. Tel.: 33-01-40-61-34-54; Fax:
33-01-40-61-34-56; E-mail: teresatf@pasteur.fr.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Allen, T. D.,
Bennion, G. R.,
Rutherford, S. A.,
Reipert, S.,
Ramalho, A.,
Kiseleva, E.,
and Goldberg, M. W.
(1997)
Scanning
19,
403-410[Medline]
[Order article via Infotrieve]
2.
Yang, Q.,
Rout, M. P.,
and Akey, C. W.
(1998)
Mol. Cell
1,
223-234[CrossRef][Medline]
[Order article via Infotrieve]
3.
Ohno, M.,
Fornerod, M.,
and Mattaj, I. W.
(1998)
Cell
92,
327-336[CrossRef][Medline]
[Order article via Infotrieve]
4.
Mattaj, I. W.,
and Englmeier, L.
(1998)
Annu. Rev. Biochem.
67,
265-306[CrossRef][Medline]
[Order article via Infotrieve]
5.
Corbett, A. H.,
and Silver, P. A.
(1997)
Microbiol. Mol. Biol. Rev.
61,
193-211[Abstract]
6.
Nigg, E. A.
(1997)
Nature
386,
779-787[CrossRef][Medline]
[Order article via Infotrieve]
7.
Fabre, E.,
and Hurt, E.
(1997)
Annu. Rev. Genet.
31,
277-313[CrossRef][Medline]
[Order article via Infotrieve]
8.
Emtage, J. L. T.,
Bucci, M.,
Watkins, J. L.,
and Wente, S. R.
(1997)
J. Cell Sci.
110,
911-925[Abstract]
9.
Teixeira, M. T.,
Siniossoglou, S.,
Podtelejnikov, S.,
Benichou, J. C.,
Mann, M.,
Dujon, B.,
Hurt, E.,
and Fabre, E.
(1997)
EMBO J.
16,
5086-5097[CrossRef][Medline]
[Order article via Infotrieve]
10.
Fabre, E.,
Boelens, W. C.,
Wimmer, C.,
Mattaj, I. W.,
and Hurt, E. C.
(1994)
Cell
78,
275-289[CrossRef][Medline]
[Order article via Infotrieve]
11.
Wente, S. R.,
and Blobel, G.
(1994)
J. Cell Biol.
125,
955-969 12.
Dockendorff, T. C.,
Heath, C. V.,
Goldstein, A. L.,
Snay, C. A.,
and Cole, C. N.
(1997)
Mol. Cell. Biol.
17,
906-920[Abstract]
13.
Siniossoglou, S.,
Wimmer, C.,
Rieger, M.,
Doye, V.,
Tekotte, H.,
Weise, C.,
Emig, S.,
Segref, A.,
and Hurt, E. C.
(1996)
Cell
84,
265-275[CrossRef][Medline]
[Order article via Infotrieve]
14.
Radu, A.,
Moore, M. S.,
and Blobel, G.
(1995)
Cell
81,
215-222[CrossRef][Medline]
[Order article via Infotrieve]
15.
Powers, M.,
Macauley, C.,
Masiarz, F. R.,
and Forbes, D. J.
(1995)
J. Cell Biol.
128,
721-736 16.
Powers, M. A.,
Forbes, D. J.,
Dahlberg, J. E.,
and Lund, E.
(1997)
J. Cell Biol.
136,
241-250 17.
Fontoura, B. M.,
Blobel, G.,
and Matunis, M. J.
(1999)
J. Cell Biol.
144,
1097-1112 18.
Gari, E.,
Piedrafita, L.,
Aldea, M.,
and Herrero, E.
(1997)
Yeast
13,
837-848[CrossRef][Medline]
[Order article via Infotrieve]
19.
Meilhoc, E.,
Masson, J. M.,
and Teissie, J.
(1990)
Bio/Technology
8,
223-227[CrossRef][Medline]
[Order article via Infotrieve]
20.
Fairhead, C.,
Llorente, B.,
Denis, F.,
Soler, M.,
and Dujon, B.
(1996)
Yeast
12,
1439-57[CrossRef][Medline]
[Order article via Infotrieve]
21.
Ma, H.,
Kunes, S.,
Schatz, P. J.,
and Botstein, D.
(1987)
Gene (Amst.)
58,
201-216[CrossRef][Medline]
[Order article via Infotrieve]
22.
Chen, D.-C.,
Yang, B.-C.,
and Kuo, T.-T.
(1992)
Curr. Genet.
21,
83-84[CrossRef][Medline]
[Order article via Infotrieve]
23.
Aris, J. P.,
and Blobel, G.
(1988)
J. Cell Biol.
107,
17-31 24.
Marshak, D. R.,
Kadonaga, J. T.,
Burguess, R. R.,
Knuth, M. W.,
Brennan, W. A. J.,
and Lin, S.-H.
(1996)
Strategies For Protein Purification And Characterization: A Laboratory Course Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
25.
Sherman, F.,
Fink, G. R.,
and Hicks, J. B. N.
(1986)
Methods in Yeast Genetics: A Laboratory Course Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26.
Arthur, T. M.,
and Burgess, R. R.
(1998)
J. Biol. Chem.
273,
31381-31387 27.
Colland, F.,
Orsini, G.,
Brody, E. N.,
Buc, H.,
and Kolb, A.
(1998)
Mol. Microbiol.
27,
819-829[CrossRef][Medline]
[Order article via Infotrieve]
28.
Perler, F. B.
(1998)
Nat. Struct. Biol.
5,
249-252[CrossRef][Medline]
[Order article via Infotrieve]
29.
Guan, C.,
Cui, T.,
Rao, V.,
Liao, W.,
Benner, J.,
Lin, C. L.,
and Comb, D.
(1996)
J. Biol. Chem.
271,
1732-1737 30.
Xu, M. Q.,
and Perler, F. B.
(1996)
EMBO J.
15,
5146-5153[Medline]
[Order article via Infotrieve]
31.
Jencks, W. P.,
Cordes, S.,
and Carriulo, J.
(1960)
J. Biol. Chem.
235,
3608-3614 32.
Porter, J. A.,
von Kessler, D. P.,
Ekker, S. C.,
Young, K. E.,
Lee, J. J.,
Moses, K.,
and Beachy, P. A.
(1995)
Nature
374,
363-366[CrossRef][Medline]
[Order article via Infotrieve]
33.
Chong, S.,
Williams, K. S.,
Wotkowicz, C.,
and Xu, M. Q.
(1998)
J. Biol. Chem.
273,
10567-10577 34.
Burns, J. A.,
Butler, J. C.,
Moran, J.,
and Whitesides, G. M.
(1991)
J. Org. Chem.
56,
2648-2650[CrossRef]
35.
Iwai, K.,
and Ando, T.
(1967)
Methods Enzymol.
XI,
263-282
36.
Shao, Y.,
Xu, M. Q.,
and Paulus, H.
(1996)
Biochemistry
35,
3810-3815[CrossRef][Medline]
[Order article via Infotrieve]
37.
van Poelje, P. D.,
and Snell, E. E.
(1990)
Annu. Rev. Biochem.
59,
29-59[Medline]
[Order article via Infotrieve]
38.
Schmidtke, G.,
Kraft, R.,
Kostka, S.,
Henklein, P.,
Frommel, C.,
Lowe, J.,
Huber, R.,
Kloetzel, P. M.,
and Schmidt, M.
(1996)
EMBO J.
15,
6887-6898[Medline]
[Order article via Infotrieve]
39.
Guan, C.,
Liu, Y.,
Shao, Y.,
Cui, T.,
Liao, W.,
Ewel, A.,
Whitaker, R.,
and Paulus, H.
(1998)
J. Biol. Chem.
273,
9695-9702 40.
Porter, J. A.,
Young, K. E.,
and Beachy, P. A.
(1996)
Science
274,
255-259 41.
Porter, J. A.,
Ekker, S. C.,
Park, W. J.,
von Kessler, D. P.,
Young, K. E.,
Chen, C. H.,
Ma, Y.,
Woods, A. S.,
Cotter, R. J.,
Koonin, E. V.,
and Beachy, P. A.
(1996)
Cell
86,
21-34[CrossRef][Medline]
[Order article via Infotrieve]
42.
Little, J. W.
(1993)
J. Bacteriol.
175,
4943-4950
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. A. Ratner, A. E. Hodel, and M. A. Powers Molecular Determinants of Binding between Gly-Leu-Phe-Gly Nucleoporins and the Nuclear Pore Complex J. Biol. Chem., November 23, 2007; 282(47): 33968 - 33976. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Barbash Nup96-Dependent Hybrid Lethality Occurs in a Subset of Species From the simulans Clade of Drosophila Genetics, May 1, 2007; 176(1): 543 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Denning and M. F. Rexach Rapid Evolution Exposes the Boundaries of Domain Structure and Function in Natively Unfolded FG Nucleoporins Mol. Cell. Proteomics, February 1, 2007; 6(2): 272 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Parry, S. Ward, A. Cernac, S. Dharmasiri, and M. Estelle The Arabidopsis SUPPRESSOR OF AUXIN RESISTANCE Proteins Are Nucleoporins with an Important Role in Hormone Signaling and Development PLANT CELL, July 1, 2006; 18(7): 1590 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Robinson, S. Park, Z.-Y. J. Sun, P. A. Silver, G. Wagner, and J. M. Hogle Multiple Conformations in the Ligand-binding Site of the Yeast Nuclear Pore-targeting Domain of Nup116p J. Biol. Chem., October 21, 2005; 280(42): 35723 - 35732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lutzmann, R. Kunze, K. Stangl, P. Stelter, K. F. Toth, B. Bottcher, and E. Hurt Reconstitution of Nup157 and Nup145N into the Nup84 Complex J. Biol. Chem., May 6, 2005; 280(18): 18442 - 18451. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Lin, G.-W. Chang, J. Q. Davies, M. Stacey, J. Harris, and S. Gordon Autocatalytic Cleavage of the EMR2 Receptor Occurs at a Conserved G Protein-coupled Receptor Proteolytic Site Motif J. Biol. Chem., July 23, 2004; 279(30): 31823 - 31832. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Bai, J. Rouquette, M. Umeda, W. Faigle, D. Loew, S. Sazer, and V. Doye The Fission Yeast Nup107-120 Complex Functionally Interacts with the Small GTPase Ran/Spi1 and Is Required for mRNA Export, Nuclear Pore Distribution, and Proper Cell Division Mol. Cell. Biol., July 15, 2004; 24(14): 6379 - 6392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. C. De Souza, K. P. Horn, K. Masker, and S. A. Osmani The SONBNUP98 Nucleoporin Interacts With the NIMA Kinase in Aspergillus nidulans Genetics, November 1, 2003; 165(3): 1071 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vasu, S. Shah, A. Orjalo, M. Park, W. H. Fischer, and D. J. Forbes Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export J. Cell Biol., October 29, 2001; 155(3): 339 - 354. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||